Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Diagnostic Challenges in Rare Infections and Crystal Deposition in Immunocompromised Patients

Description

The talk presented two challenging dermatopathology cases in immunocompromised patients. The first was a premature newborn with an ulcerated crusted plaque whose biopsy showed strongly birefringent calcium oxalate crystals; although the differential included several crystal and infectious processes, the lesion was ultimately diagnosed as cutaneous aspergillosis, because Aspergillus species can produce oxalic acid that forms calcium oxalate crystals in tissue. This case emphasized that oxalate crystals can be an important clue to Aspergillus infection, even when primary or secondary hyperoxaluria is also considered. The second case involved an elderly immunocompromised patient with ulcerative skin lesions on the arm and face. Biopsy showed a neutrophilic and granulomatous infiltrate with organisms consistent with Acanthamoeba, a free-living protozoan found in water, soil, and dust that can cause keratitis, CNS disease, and cutaneous or disseminated infection in immunosuppressed hosts. The speaker reviewed key mimics such as Buruli ulcer, cryptococcosis, coccidioidomycosis, and leishmaniasis, and noted that PCR can help confirm Acanthamoeba. The patient improved after multidrug therapy, reinforcing the need to consider rare infections in immunocompromised patients.

View more

Conclusions

  • Calcium oxalate crystals in skin tissue can be an important diagnostic clue for Aspergillus infection, especially when fungal hyphae with acute-angle branching are present.
  • Primary hyperoxaluria can cause vascular oxalate deposition with skin ischemia and gangrene, but in the presented case the oxalate crystals were actually secondary to cutaneous aspergillosis.
  • Calcium phosphate, hyaluronic acid, polylactic acid, and urate have distinct histologic appearances that can be differentiated from oxalate on polarized and routine microscopy.
  • In an immunocompromised patient with ulcerated skin lesions, Acanthamoeba should be considered because it can present as cutaneous nodules, ulcers, or eschars and may mimic macrophages histologically.
  • Acanthamoebiasis is a rare but treatable free-living protozoal infection, and PCR or immunohistochemical testing may be needed for confirmation when tissue morphology is equivocal.
  • Buruli ulcer, cryptococcosis, coccidioidomycosis, and leishmaniasis are important mimickers in ulcerative skin disease, but their clinical and histologic hallmarks distinguish them from Acanthamoeba infection.
  • Aggressive multidrug therapy can lead to healing of cutaneous Acanthamoeba infection, even in heavily immunocompromised patients.
  • The presentation emphasizes that unusual infections should remain on the differential diagnosis for immunocompromised patients with atypical ulcers or eschars.
  • Meyer SN, et al. J Cutan Pathol. 2024 Feb;51(2):88-91. doi: 10.1111/cup.14533. Epub 2023 Sep 12. PMID: 37699723.#10.1111/cup.14533
  • Requena L, et al. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011 Jan;64(1):1-34. PMID: 21167403.#10.1016/j.jaad.2010.02.064
  • Urate crystals arranged in fascicles. J Cutan Pathol, Volume: 36, Issue: 5, Pages: 560-564, First published: 30 March 2009, DOI: 10.1111/j.1600-0560.2008.01116.x.#10.1111/j.1600-0560.2008.01116.x
  • Blackmon and colleagues' 2011 article on cutaneous oxalosis.
  • Stetkevich SA, et al. JAAD Case Rep. 2022 Aug 10;28:77-79. doi: 10.1016/j.jdcr.2022.08.008. PMID: 36097622.#10.1016/j.jdcr.2022.08.008
  • Siddiqui N, Wu B, Gunnell L, George E, Chang O. Cutaneous Acanthamoebiasis: Two Cases Highlighting Diverse Histopathologic Findings. J Cutan Pathol. 2025 Nov;52(11):681-685. doi: 10.1111/cup.14854. Epub 2025 Aug 17. PMID: 40820565.#10.1111/cup.14854
  • Stekevich SA, et al. JAAD Case Rep. 2022 Aug 10;28:77-79. doi: 10.1016/j.jdcr.2022.08.008. PMID: 36097622.#10.1016/j.jdcr.2022.08.008